No abstract available
Keywords:
disease activity; systemic lupus erythematosus; treatment.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Calcineurin Inhibitors / therapeutic use
-
Clinical Trials, Phase II as Topic
-
Clinical Trials, Phase III as Topic
-
Cyclosporine / therapeutic use*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lupus Erythematosus, Systemic / drug therapy*
-
Safety
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Calcineurin Inhibitors
-
Immunosuppressive Agents
-
voclosporin
-
anifrolumab
-
belimumab
-
Cyclosporine